ESG Data Tables
2021 Facts and Figures
Innovation
| 2020 | 2021 | Year-over-Year Changes | |
|---|---|---|---|
| R&D spending | 2020$61 m | 2021$73 m | Year-over-Year Changes+$12 m |
| R&D ratio | 202010.3% | 202110.3% | Year-over-Year Changes0 |
| Revenue | 2020$591 m | 2021$707 m | Year-over-Year Changes+$116 m |
| End market ratio Medical | Advanced Industrial |
202056% | 44% | 202152% | 48% | Year-over-Year Changes-4 | +4 |
| Vitality Index (Revenue from products introduced in last 4 years as % of total consolidated revenue excluding current-year acquisitions) |
202028% | 202129% | Year-over-Year Changes+1 |
People
| Board of Directors | 2020 | 2021 | Year-over-Year Changes |
|---|---|---|---|
| Board of DirectorsGender diversity (f | m)* | 202025% | 75% | 202133% | 67% | Year-over-Year Changes+8 | -8 |
| Board of DirectorsUnderrepresented groups** | Non-underrepresented groups* |
202013% | 87% | 202111% | 89% | Year-over-Year Changes-2 | +2 |
| * As of December 31, 2020 and December 31, 2021, respectively. ** An underrepresented group in the U.S. is anyone who self-identifies as Black, African American, Hispanic or Latinx, Asian, Native American or Alaska Native, Native Hawaiian or Pacific Islander, or two or more races or ethnicities, as defined by Nasdaq. | |||
| Women | Men ratio | |||
| Women | Men ratioTotal headcount (f | m) | 202035% | 65% | 202136% | 64% | Year-over-Year Changes+1 | -1 |
| Women | Men ratioIndividual contributor positions (f | m) | 202037% | 63% | 202139% | 61% | Year-over-Year Changes+2 | -2 |
| Women | Men ratioLeadership positions (f | m) | 202025% | 75% | 202125% | 75% | Year-over-Year Changes0 | 0 |
| Women | Men ratio*** | |||
| Women | Men ratioTotal headcount (f | m) | 202035% | 65% | 202136% | 64% | Year-over-Year Changes+1 | -1 |
| Women | Men ratioIndividual contributor positions (f | m) | 202037% | 63% | 202138% | 62% | Year-over-Year Changes+1 | -1 |
| Women | Men ratioLeadership positions (f | m) | 202025% | 75% | 202127% | 73% | Year-over-Year Changes+2 | -2 |
| *** Excluding new acquisitions in 2021 | |||
| Employees trained on Compliance (excluding direct-labor production employees) |
202096% | 202197% | Year-over-Year Changes+1 |
Innovation
R&D spending | |
|---|---|
2020 | $61 m |
2021 | $73 m |
Year-over-Year Changes | +$12 m |
R&D ratio | |
|---|---|
2020 | 10.3% |
2021 | 10.3% |
Year-over-Year Changes | 0 |
Revenue | |
|---|---|
2020 | $591 m |
2021 | $707 m |
Year-over-Year Changes | +$116 m |
End market ratio Medical | Advanced Industrial | |
|---|---|
2020 | 56% | 44% |
2021 | 52% | 48% |
Year-over-Year Changes | -4 | +4 |
Vitality Index (Revenue from products introduced in last 4 years as % of total consolidated revenue excluding current-year acquisitions) | |
|---|---|
2020 | 28% |
2021 | 29% |
Year-over-Year Changes | +1 |
People
Board of Directors Gender diversity (f | m)* | |
|---|---|
2020 | 25% | 75% |
2021 | 33% | 67% |
Year-over-Year Changes | +8 | -8 |
Underrepresented groups** | Non-underrepresented groups* | |
|---|---|
2020 | 13% | 87% |
2021 | 11% | 89% |
Year-over-Year Changes | -2 | +2 |
* As of December 31, 2020 and December 31, 2021, respectively. ** An underrepresented group in the U.S. is anyone who self-identifies as Black, African American, Hispanic or Latinx, Asian, Native American or Alaska Native, Native Hawaiian or Pacific Islander, or two or more races or ethnicities, as defined by Nasdaq. | |
Women | Men ratio Total headcount (f | m) | |
|---|---|
2020 | 35% | 65% |
2021 | 36% | 64% |
Year-over-Year Changes | +1 | -1 |
Individual contributor positions (f | m) | |
|---|---|
2020 | 37% | 63% |
2021 | 39% | 61% |
Year-over-Year Changes | +2 | -2 |
Leadership positions (f | m) | |
|---|---|
2020 | 25% | 75% |
2021 | 25% | 75% |
Year-over-Year Changes | 0 | 0 |
Women | Men ratio*** Total headcount (f | m) | |
|---|---|
2020 | 35% | 65% |
2021 | 36% | 64% |
Year-over-Year Changes | +1 | -1 |
Individual contributor positions (f | m) | |
|---|---|
2020 | 37% | 63% |
2021 | 38% | 62% |
Year-over-Year Changes | +1 | -1 |
Leadership positions (f | m) | |
|---|---|
2020 | 25% | 75% |
2021 | 27% | 73% |
Year-over-Year Changes | +2 | -2 |
*** Excluding new acquisitions in 2021 | |
Employees trained on Compliance (excluding direct-labor production employees) | |
|---|---|
2020 | 96% |
2021 | 97% |
Year-over-Year Changes | +1 |